2016
DOI: 10.1038/srep21524
|View full text |Cite
|
Sign up to set email alerts
|

Pyruvate Kinase M2 Activates mTORC1 by Phosphorylating AKT1S1

Abstract: In cancer cells, the mammalian target of rapamycin complex 1 (mTORC1) that requires hormonal and nutrient signals for its activation, is constitutively activated. We found that overexpression of pyruvate kinase M2 (PKM2) activates mTORC1 signaling through phosphorylating mTORC1 inhibitor AKT1 substrate 1 (AKT1S1). An unbiased quantitative phosphoproteomic survey identified 974 PKM2 substrates, including serine202 and serine203 (S202/203) of AKT1S1, in the proteome of renal cell carcinoma (RCC). Phosphorylation… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
100
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 100 publications
(102 citation statements)
references
References 64 publications
(79 reference statements)
2
100
0
Order By: Relevance
“…In T cells, during high glycolytic flux, GAPDH has been shown to induce translation of IFNg and IL-2 while it's interaction with Rheb is inhibited, releasing Rheb to activate mTORC1 40,42 . Similarly, PKM2, one of two transcripts of PKM, can activate mTORC1 by phosphorylating another inhibitor AKT1S1, which could account for increased mTORC1 activation in rapidly cycling cells 43 . GPI, yet another glycolytic enzyme, has been shown to promote growth, increase motility of fibroblasts in a tumor setting, and can be inhibited by the insulin growth factor binding protein 3 (IGFBP3) 40 .…”
Section: Discussionmentioning
confidence: 99%
“…In T cells, during high glycolytic flux, GAPDH has been shown to induce translation of IFNg and IL-2 while it's interaction with Rheb is inhibited, releasing Rheb to activate mTORC1 40,42 . Similarly, PKM2, one of two transcripts of PKM, can activate mTORC1 by phosphorylating another inhibitor AKT1S1, which could account for increased mTORC1 activation in rapidly cycling cells 43 . GPI, yet another glycolytic enzyme, has been shown to promote growth, increase motility of fibroblasts in a tumor setting, and can be inhibited by the insulin growth factor binding protein 3 (IGFBP3) 40 .…”
Section: Discussionmentioning
confidence: 99%
“…The interaction of Hsp90 with PKM2 and Akt has been found in oxidative stress and tumor experiments [30,31]. PKM2 serves as an upstream molecule of Akt to regulate Akt expression and the phosphorylation of Akt-1 substrate 1 [33,45]. Consistently, heat stress stimulated the functional consumption of PKM2 to maintain Akt protein levels and enhance its activation through the sustained interaction of Hsp90 and PKM2.…”
Section: Discussionmentioning
confidence: 86%
“…Further analyses of the downstream molecules revealed upregulated phosphoproteins belonging to the mTOR complex 1/2 (mTORC1/2) pathways, including AKT1S1, RPTOR, RICTOR, and RPS6. It was previously shown that the S202/S203 phosphorylation of AKT1S1 results in the activation of mTORC1 signaling 46 . RPTOR S863 phosphorylation activates and increases the activity of mTORC1 47 .…”
Section: Discussionmentioning
confidence: 99%